Sweden · Delayed Price · Currency is SEK Medicover AB Statistics
Total Valuation
Medicover AB has a market cap or net worth of SEK 33.43 billion. The enterprise value is 48.77 billion.
| Market Cap | 33.43B |
| Enterprise Value | 48.77B |
Important Dates
The last earnings date was Wednesday, July 22, 2026.
| Earnings Date | Jul 22, 2026 |
| Ex-Dividend Date | Apr 30, 2026 |
Share Statistics
Medicover AB has 151.97 million shares outstanding. The number of shares has increased by 0.61% in one year.
| Current Share Class | 75.42M |
| Shares Outstanding | 151.97M |
| Shares Change (YoY) | +0.61% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 11.52% |
| Owned by Institutions (%) | 26.52% |
| Float | 52.98M |
Valuation Ratios
The trailing PE ratio is 35.40 and the forward PE ratio is 26.28. Medicover AB's PEG ratio is 0.89.
| PE Ratio | 35.40 |
| Forward PE | 26.28 |
| PS Ratio | 1.22 |
| PB Ratio | 5.46 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 16.21 |
| P/OCF Ratio | 8.75 |
| PEG Ratio | 0.89 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.12, with an EV/FCF ratio of 23.64.
| EV / Earnings | 51.88 |
| EV / Sales | 1.78 |
| EV / EBITDA | 11.12 |
| EV / EBIT | 25.06 |
| EV / FCF | 23.64 |
Financial Position
The company has a current ratio of 0.55, with a Debt / Equity ratio of 2.64.
| Current Ratio | 0.55 |
| Quick Ratio | 0.48 |
| Debt / Equity | 2.64 |
| Debt / EBITDA | 3.69 |
| Debt / FCF | 7.85 |
| Interest Coverage | 2.68 |
Financial Efficiency
Return on equity (ROE) is 15.49% and return on invested capital (ROIC) is 6.83%.
| Return on Equity (ROE) | 15.49% |
| Return on Assets (ROA) | 4.66% |
| Return on Invested Capital (ROIC) | 6.83% |
| Return on Capital Employed (ROCE) | 11.94% |
| Weighted Average Cost of Capital (WACC) | 9.50% |
| Revenue Per Employee | 557,685 |
| Profits Per Employee | 19,185 |
| Employee Count | 49,000 |
| Asset Turnover | 1.04 |
| Inventory Turnover | 30.11 |
Taxes
In the past 12 months, Medicover AB has paid 317.79 million in taxes.
| Income Tax | 317.79M |
| Effective Tax Rate | 26.31% |
Stock Price Statistics
The stock price has decreased by -19.96% in the last 52 weeks. The beta is 1.50, so Medicover AB's price volatility has been higher than the market average.
| Beta (5Y) | 1.50 |
| 52-Week Price Change | -19.96% |
| 50-Day Moving Average | 218.97 |
| 200-Day Moving Average | 217.79 |
| Relative Strength Index (RSI) | 55.84 |
| Average Volume (20 Days) | 46,938 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medicover AB had revenue of SEK 27.33 billion and earned 940.08 million in profits. Earnings per share was 6.21.
| Revenue | 27.33B |
| Gross Profit | 6.39B |
| Operating Income | 1.96B |
| Pretax Income | 1.21B |
| Net Income | 940.08M |
| EBITDA | 4.38B |
| EBIT | 1.95B |
| Earnings Per Share (EPS) | 6.21 |
Balance Sheet
The company has 1.03 billion in cash and 16.18 billion in debt, with a net cash position of -15.16 billion or -99.74 per share.
| Cash & Cash Equivalents | 1.03B |
| Total Debt | 16.18B |
| Net Cash | -15.16B |
| Net Cash Per Share | -99.74 |
| Equity (Book Value) | 6.13B |
| Book Value Per Share | 39.11 |
| Working Capital | -4.80B |
Cash Flow
In the last 12 months, operating cash flow was 3.82 billion and capital expenditures -1.76 billion, giving a free cash flow of 2.06 billion.
| Operating Cash Flow | 3.82B |
| Capital Expenditures | -1.76B |
| Depreciation & Amortization | 1.13B |
| Net Borrowing | -797.75M |
| Free Cash Flow | 2.06B |
| FCF Per Share | 13.57 |
Margins
Gross margin is 23.37%, with operating and profit margins of 7.18% and 3.44%.
| Gross Margin | 23.37% |
| Operating Margin | 7.18% |
| Pretax Margin | 4.42% |
| Profit Margin | 3.44% |
| EBITDA Margin | 16.06% |
| EBIT Margin | 7.13% |
| FCF Margin | 7.55% |
Dividends & Yields
This stock pays an annual dividend of 2.21, which amounts to a dividend yield of 1.01%.
| Dividend Per Share | 2.21 |
| Dividend Yield | 1.01% |
| Dividend Growth (YoY) | 32.24% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 35.57% |
| Buyback Yield | -0.61% |
| Shareholder Yield | 0.40% |
| Earnings Yield | 2.81% |
| FCF Yield | 6.17% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Medicover AB is 252.95, which is 10.90% higher than the current price. The consensus rating is "Buy".
| Price Target | 252.95 |
| Price Target Difference | 10.90% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 11.01% |
| EPS Growth Forecast (3Y) | 22.36% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Medicover AB has an Altman Z-Score of 2.15 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.15 |
| Piotroski F-Score | 7 |